Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,230.12
(
0.29%
)
US TECH 100
26,942.00
(
0.87%
)
Dow Jones
49,499.27
(
-0.31%
)
Brent Oil
107.80
(
0.00%
)
Bitcoin
78,125.96
(
-0.09%
)
News Focus
News Focus
Post# of 824053
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

CrashOverride

Send PM Follow Ignore
Followers 96
Posts 5080
Boards Moderated 0
Alias Born 02/07/2021

CrashOverride

Re: HappyLibrarian post# 532139

Monday, 11/14/2022 4:33:21 PM

Monday, November 14, 2022 4:33:21 PM

Post# of 824053
The vaccine's created from one tumor sample per the trial design. Adjuvants and neoadjuvants will increase efficacy as we see from newer trials. It would be very intrusive to have a second surgical resection for rGBM patients so I do not believe clinicians will want to do that given the already excellent cure rates we see for those patients.

Do your own research. I am not providing legal or investment advice. This is an anonymous forum for entertainment purposes only. Don't trust anything you read.

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent NWBO News
More NWBO News